Exagen (XGN) Accumulated Expenses (2018 - 2026)

Exagen (XGN) has 9 years of Accumulated Expenses data on file, last reported at $4.8 million in Q1 2026.

• Quarterly Accumulated Expenses fell 3.56% year-over-year to $4.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.8 million (down 3.56% YoY) and the FY2025 annual result came in at $6.3 million, down 8.52% from the prior year.
• Accumulated Expenses eased to $4.8 million in Q1 2026, from $6.3 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $7.5 million in Q4 2023 to a low of $4.8 million in Q1 2026.
• A 5-year average of $6.0 million and a median of $6.0 million in 2024 frame the typical range for Accumulated Expenses.
• Annual changes were most pronounced in 2022 — Accumulated Expenses declined 21.67% — and 2023, when it jumped 40.85%.
• Tracing XGN's Accumulated Expenses over 5 years: stood at $5.3 million in 2022, then surged by 40.85% to $7.5 million in 2023, then retreated by 8.17% to $6.9 million in 2024, then slipped by 8.52% to $6.3 million in 2025, then dropped by 24.58% to $4.8 million in 2026.
• The last three Accumulated Expenses figures came in at $4.8 million (Q1 2026), $6.3 million (Q4 2025), and $5.7 million (Q3 2025), per Business Quant data.